FN2 Earnings Intelligence
CME Group Inc. ratios (quarterly)
CME Group Inc. (CME) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,405.3 | $1,981.3 | $2,446.8 | $2,391.2 | $2,144.2 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $1,642.3 | $1,692 | $1,537.6 | $1,880.1 | $1,706.2 | $1,696.6 | $1,745 |
| % Growth | - | - | - | - | - | 10.3% | - |
| Gross Profit | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| EBITDA | $1,135.3 | $1,156.6 | $999 | $1,336.9 | $1,135.3 | - | - |
| % Margin | 69.1% | 68.4% | 65.0% | 71.1% | 66.5% | - | - |
| Net Income | $956.2 | $1,025.1 | $908 | $1,154.3 | $1,041.8 | - | - |
| % Margin | 58.2% | 60.6% | 59.1% | 61.4% | 61.1% | - | - |
| Diluted EPS | $2.62 | $2.81 | $2.49 | $3.18 | $2.88 | $2.94 | $2.97 |
| % Growth | - | - | - | - | - | 18.1% | - |
| Operating Cash Flow | $1,116.6 | - | - | $1,259.9 | - | - | - |
| CapEx | $14.2 | - | - | $21.8 | - | - | - |
| Free Cash Flow | $1,102.4 | - | - | $1,238.1 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $1,642.3 | $1,692 | $1,537.6 | $1,880.1 | $1,706.2 | $1,696.6 | $1,745 |
| Gross Profit | - | - | - | - | - | - | - |
| EBITDA | $1,135.3 | $1,156.6 | $999 | $1,336.9 | $1,135.3 | - | - |
| Net Income | $956.2 | $1,025.1 | $908 | $1,154.3 | $1,041.8 | - | - |
| Diluted EPS | $2.62 | $2.81 | $2.49 | $3.18 | $2.88 | $2.94 | $2.97 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,405.3 | $1,981.3 | $2,446.8 | $2,391.2 | $2,144.2 |
| Short-term Debt | $0 | $0 | $0 | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1,116.6 | - | - | $1,259.9 | - |
| Capital Expenditure | $14.2 | - | - | $21.8 | - |
| Free Cash Flow | $1,102.4 | - | - | $1,238.1 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | 69.1% | 68.4% | 65.0% | 71.1% | 66.5% |
| Net Margin | 58.2% | 60.6% | 59.1% | 61.4% | 61.1% |
| FCF Margin | 67.1% | - | - | 65.9% | - |
| Diluted EPS Growth | - | - | - | - | - |